For most people taking it for autoimmune conditions like rheumatoid arthritis or psoriasis, methotrexate is considered safe when monitored with routine blood tests. It has been used at low doses for decades, and it remains the first-line treatment for rheumatoid arthritis worldwide. That said, “safe” doesn’t mean “side-effect free.” About a third of people experience nausea, and the drug requires regular lab work to catch liver or blood cell problems early. Understanding what to expect, and what to watch for, makes a real difference in how well treatment goes.
Low-Dose vs. High-Dose: Two Different Drugs
Methotrexate was originally developed as a chemotherapy agent, and that association understandably makes people nervous. But the doses used for autoimmune conditions are dramatically different. Chemotherapy doses can reach 1,000 milligrams in a single session. For rheumatoid arthritis or psoriasis, the typical dose is 15 to 25 milligrams once a week.
The two doses even work through different biological pathways. At high doses, methotrexate shuts down cell division directly, which is how it kills cancer cells. At low doses, it works primarily by increasing levels of adenosine, a natural molecule that dials down inflammation throughout the body. This is why folic acid supplements, which would counteract the chemotherapy effect, don’t reduce the drug’s effectiveness for arthritis. They’re actually prescribed alongside it to minimize side effects.
Common Side Effects and How Often They Happen
A large UK study tracking over 1,000 early rheumatoid arthritis patients during their first year on methotrexate found that gastrointestinal problems were the most frequent complaint, affecting 42% of patients overall. Nausea specifically hit 31.2% of people. Fatigue was nearly as common at 29.4%. Headaches occurred in 19%, oral ulcers in 12%, and hair thinning in about 9%.
These numbers sound high, but context matters. Many of these side effects are mild and manageable, particularly with folic acid supplementation. Evidence supports taking 5 to 10 milligrams of folic acid per week alongside methotrexate to reduce gastrointestinal and mucosal symptoms. Interestingly, higher doses of folic acid (30 milligrams per week) don’t appear to offer additional benefit over the standard dose. Most rheumatologists prescribe folic acid as a matter of course.
Nausea tends to hit within a day or two of the weekly dose, and some people find that switching from oral tablets to subcutaneous injections significantly reduces stomach-related side effects.
Serious Risks: Liver, Lungs, and Blood Cells
The risks that genuinely concern doctors fall into three categories: liver damage, lung inflammation, and suppression of blood cell production. All three are uncommon with proper monitoring, but they’re the reason you need regular blood work.
Liver toxicity gets the most attention, but actual clinically significant liver damage is rare at low doses. One study found that only a single patient in the entire cohort had liver enzymes elevated beyond twice the normal upper limit, and there was poor correlation between the total amount of methotrexate someone had taken over time and actual liver scarring on biopsy. Still, if blood tests show rising liver enzymes, the standard approach is to lower the dose and recheck in two to four weeks. If levels stay elevated above twice normal, the drug is paused for one to two weeks.
Methotrexate-associated lung inflammation (pneumonitis) is reported in 0.3% to 11.6% of patients, with that wide range reflecting differences in how studies define and detect it. Symptoms include dry cough, shortness of breath, and fever, appearing in more than 80% of affected cases. This is an unpredictable reaction rather than a dose-dependent one, meaning it can happen at any point during treatment. It typically resolves after stopping the medication, but it requires prompt medical attention.
Blood cell suppression, where the bone marrow produces fewer white blood cells, red blood cells, or platelets, is the reason complete blood counts are part of routine monitoring. Catching a downward trend early allows for dose adjustment before it becomes a problem.
What Monitoring Looks Like
The American College of Rheumatology strongly recommends blood tests including a complete blood count, liver function tests, and kidney function tests within the first one to two months of starting methotrexate, then every three to four months for as long as you’re on it. Baseline labs are drawn before you even start the drug to establish your normal values and rule out any pre-existing issues that would make methotrexate a poor choice.
This schedule is not optional or overly cautious. It’s the core safety mechanism that makes long-term methotrexate use viable. If you’re keeping up with these appointments and your numbers look stable, the drug’s serious risks drop considerably.
Drug and Lifestyle Interactions
Several common medications can raise methotrexate levels in your blood, increasing the risk of toxicity. NSAIDs like ibuprofen and naproxen reduce the kidneys’ ability to clear methotrexate. Proton pump inhibitors (omeprazole, esomeprazole, pantoprazole) may also decrease methotrexate clearance, leading to elevated levels. Penicillin-type antibiotics can reduce kidney clearance as well. If you’re prescribed any new medication while on methotrexate, your prescriber needs to know.
Alcohol is a more complicated topic. The 1994 ACR guidelines recommend abstinence with only occasional exceptions, noting that there are “no data about the quantity of alcohol that can safely be consumed with methotrexate.” In practice, many rheumatologists allow light, occasional drinking for patients with normal liver function, but regular or heavy consumption clearly adds liver stress on top of a drug that already requires liver monitoring.
Pregnancy and Conception
Methotrexate is harmful to a developing fetus and should be stopped at least three months before planned conception. This applies to women trying to become pregnant, and current guidelines recommend the same three-month washout period. During treatment, reliable contraception is essential. If you’re thinking about starting a family, your rheumatologist can switch you to a pregnancy-compatible medication well in advance.
A Cardiovascular Benefit Worth Knowing About
People with rheumatoid arthritis already face higher cardiovascular risk due to chronic inflammation. One of the more encouraging findings about long-term methotrexate use is that it appears to lower that risk rather than raise it. A meta-analysis of seven observational studies found that methotrexate use was associated with a 27% reduction in cardiovascular events, including heart attacks, strokes, and cardiovascular death. Even after adjusting for how severe someone’s arthritis was, the reduction held at 20%.
This isn’t a reason to take methotrexate for heart protection, but it does mean the drug isn’t quietly adding cardiovascular harm on top of everything else. For people who need it for their arthritis or psoriasis, this is reassuring data.